Pathophysiology, Risk Factors and Management in HFpEF Patients with Comorbidities
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 1673
Special Issue Editors
Interests: heart failure; atrial fibrillation; clinical prognosis; remodeling
Interests: heart failure; atrial fibrillation; molecular mechanism.
Special Issue Information
Dear Colleagues,
Heart failure with preserved ejection fraction (HFpEF) is a highly complex clinical syndrome, representing the most common type of heart failure. It is often characterized by a high prevalence of coexisting comorbidities, such as atrial fibrillation, diabetes mellitus, hypertension and obesity. HFpEF patients with comorbidities have higher risks of worse clinical outcomes in clinical settings. Therefore, the early identification of those HFpEF patients at a high risk of comorbidities may prompt the initiation of prevention management, and thus improve prognosis. In this research topic, we would like to create a forum for discussion on the current understanding of the pathophysiology, risk factors and management of HFpEF patients with comorbidities. We welcome submissions of original articles, reviews covering, but not limited to, the following subtopics:
- The current understanding of the pathophysiology (especially molecular mechanisms) of comorbidities in HFpEF.
- Risk factors associated with disease development, or risk models for predicting comorbidities in HFpEF.
Dr. Wengen Zhu
Dr. Jianyong Ma
Dr. Xiao Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- pathophysiology
- risk factors
- management
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
